Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

SELL
$242.49 - $301.46 $381,679 - $474,498
-1,574 Reduced 15.63%
8,499 $2.09 Million
Q2 2022

Aug 09, 2022

BUY
$224.73 - $338.64 $49,665 - $74,839
221 Added 2.24%
10,073 $2.49 Million
Q1 2022

Apr 21, 2022

BUY
$277.25 - $366.29 $456,630 - $603,279
1,647 Added 20.07%
9,852 $3.26 Million
Q4 2021

Feb 01, 2022

SELL
$300.63 - $371.35 $1.31 Million - $1.62 Million
-4,367 Reduced 34.74%
8,205 $2.95 Million
Q3 2021

Nov 15, 2021

SELL
$310.19 - $376.2 $58,936 - $71,478
-190 Reduced 1.49%
12,572 $4.09 Million
Q2 2021

Jul 30, 2021

SELL
$262.71 - $351.17 $460,530 - $615,601
-1,753 Reduced 12.08%
12,762 $3.98 Million
Q1 2021

May 03, 2021

SELL
$285.92 - $355.13 $2.25 Million - $2.79 Million
-7,860 Reduced 35.13%
14,515 $4.63 Million
Q4 2020

Jan 28, 2021

BUY
$251.88 - $324.2 $2.78 Million - $3.57 Million
11,023 Added 97.1%
22,375 $7.25 Million
Q3 2020

Nov 06, 2020

BUY
$255.22 - $317.0 $666,124 - $827,370
2,610 Added 29.86%
11,352 $3.15 Million
Q2 2020

Jul 28, 2020

SELL
$141.4 - $257.09 $535,481 - $973,599
-3,787 Reduced 30.23%
8,742 $2.11 Million
Q1 2020

May 06, 2020

BUY
$130.51 - $196.01 $473,881 - $711,712
3,631 Added 40.81%
12,529 $1.82 Million
Q3 2019

Oct 18, 2019

BUY
$175.89 - $279.23 $67,365 - $106,945
383 Added 4.5%
8,898 $1.58 Million
Q4 2018

Jan 25, 2019

SELL
$281.08 - $444.25 $108,496 - $171,480
-386 Reduced 4.34%
8,515 $2.77 Million
Q3 2018

Nov 09, 2018

SELL
$354.53 - $449.75 $56,015 - $71,060
-158 Reduced 1.74%
8,901 $4 Million
Q2 2018

Aug 06, 2018

BUY
$278.07 - $446.21 $1.85 Million - $2.96 Million
6,644 Added 275.11%
9,059 $3.71 Million
Q4 2017

Jan 31, 2018

BUY
$168.78 - $199.74 $152,577 - $180,564
904 Added 59.83%
2,415 $453,000
Q3 2017

Nov 08, 2017

BUY
$145.39 - $168.6 $219,684 - $254,754
1,511
1,511 $255,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.